Macrogenics (MGNX) Misses Q2 EPS by 11c, Misses on Revenue
Get Alerts MGNX Hot Sheet
Join SI Premium – FREE
Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.57), $0.11 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $28.06 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Capital Securities Downgrades Full House Resorts (FLL) to Hold
- ConocoPhillips (COP) PT Raised to $170 at Raymond James
- Chevron (CVX) PT Raised to $268 at Wells Fargo
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share